OrthoPediatrics (NASDAQ:KIDS) Shares Down 7.8% – Time to Sell?

OrthoPediatrics Corp. (NASDAQ:KIDS)’s share price dropped 7.8% during mid-day trading on Thursday . The stock traded as low as $28.10 and last traded at $28.54. Approximately 46,608 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 164,730 shares. The stock had previously closed at $30.95.

Wall Street Analysts Forecast Growth

KIDS has been the subject of several recent analyst reports. Truist Financial decreased their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a report on Monday, October 14th. JMP Securities restated a “market outperform” rating and issued a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th. Finally, Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Stock Performance

The company has a market capitalization of $665.53 million, a P/E ratio of -28.39 and a beta of 1.16. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 1.96. The stock’s 50 day simple moving average is $27.96 and its two-hundred day simple moving average is $29.86.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Monday, August 5th. The company reported ($0.23) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.08. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. The company had revenue of $52.80 million during the quarter, compared to the consensus estimate of $52.40 million. As a group, research analysts expect that OrthoPediatrics Corp. will post -0.92 earnings per share for the current year.

Insiders Place Their Bets

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of OrthoPediatrics stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total transaction of $293,000.00. Following the completion of the sale, the general counsel now owns 77,304 shares in the company, valued at $2,265,007.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 31.80% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. International Assets Investment Management LLC grew its holdings in OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after purchasing an additional 966 shares during the period. Quest Partners LLC acquired a new position in shares of OrthoPediatrics in the second quarter valued at approximately $34,000. EntryPoint Capital LLC boosted its holdings in shares of OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after buying an additional 1,009 shares during the period. SG Americas Securities LLC acquired a new position in shares of OrthoPediatrics in the second quarter valued at approximately $110,000. Finally, State Board of Administration of Florida Retirement System acquired a new position in shares of OrthoPediatrics in the first quarter valued at approximately $178,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.